Decision details
Use of antipsychotic medication in care homes - evidence session 14 - Social Care Wales
Decision Maker: Health, Social Care and Sport Committee - Fifth Senedd
Status: Complete
Is Key decision?: Yes
Purpose:
Inquiry5
The Health, Social Care and Sport Committee undertook a short inquiry on the use of antipsychotic medication in care homes. This was supported by stakeholders responding to the consultation on the Committee’s priorities.
Antipsychotics are a group of medications usually used in the treatment of mental health conditions such as schizophrenia. They are often inappropriately prescribed to control the behavioural and psychological symptoms of dementia. Their use in dementia patients is associated with a significant increased risk of harm. It’s been suggested that around two thirds of prescriptions of antipsychotics for people with dementia are inappropriate.
Reducing the number of people with a dementia diagnosis inappropriately receiving antipsychotic medication, particularly in care homes, was also identified as a key action in the Welsh Government’s draft dementia strategy.
As part of its work on mental health inequalities, the Sixth Senedd Health and Social Care Committee wrote to the Deputy Minister for Mental Health and Wellbeing on 11 July 2022 to seek an update on the Fifth Senedd Committee’s recommendations. The Ministers responded on 31 January 2023.
Terms of reference:
The Committee looked at the use of antipsychotic medication in care home settings, and the ways in which its inappropriate use could be reduced, including the consideration of:
- the
availability of data on the prescribing of antipsychotics in care homes,
to understand prevalence and patterns of use;
- prescribing
practices, including implementation of clinical guidance and medication
reviews;
- provision
of alternative (non-pharmacological) treatment options;
- training
for health and care staff to support the provision of person-centred care
for care home residents living with dementia;
- identifying
best practice, and the effectiveness of initiatives introduced so far to
reduce inappropriate prescribing of antipsychotics;
- use of
antipsychotic medication for people with dementia in other types of care
settings.
Evidence gathering
The Committee was inviting views on this issue. The deadline for responses was 21 April 2017.
Decisions:
2.1
The Committee received evidence from Gerry Evans, Social Care Wales.
Publication date: 15/11/2017
Date of decision: 25/10/2017
Decided at meeting: 25/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd
Accompanying Documents: